CDD to Present at World Malaria Day Event

CDD will be presenting a talk and two posters at a Zagaya World Malaria Day Event this Thursday (April 25) in Emeryville.

World Malaria Day banner

Although the case studies and examples are for Malaria, it is worth noting that the CDD Vault technology is “therapeutic area agnostic” and thus equally applicable to commercial applications.   You can still register to attend: http://www.zagaya.org/wmd2013-register/

Here is the full program:

World Malaria Day 2013 Program

9:00 am – 9:10 am: Welcome

Kay Monroe, Executive Director, Zagaya

9:10 am – 9:25 am: Keynote Address

Sir Richard Feachem, Director of the Global Health Group at UCSF Global Health Sciences

9:25 am – 9:35 am: Session and SoundBites Introductions, Master of Ceremonies

Max Schubert, Associate Scientist, Amyris Inc.

9:35 am – 10:10 am: Session 1: Research and Exploration

Panel 1: Co-infection and Malaria Parasite Biology
Shirley Luckhart, Chair
Professor, Dept of Medical Microbiology and Immunology, UC Davis

  • Overview of co-infection and malaria parasite biology, Rene Tsolis
  • Malaria-induced IL-10 contributes to the systemic burden of non-typhoidal Salmonella, Jason Mooney
  • The pharmacology of artemisinin combination therapies, Francesca Aweeka
  • Impact of choice of antimalarial treatment regimen on the selection of drug resistance-mediating polymorphisms in Plasmodium falciparum in Uganda, Melissa Conrad
  • The Effect of Storage Conditions and DNA Extraction Methods on the Molecular Analysis of Plasmodia from Dried Blood Spots, Alanna Schwartz

10:10 am – 10:20 am: Q&A

10:20 am – 10:50 am: Session 1, Panel 2: Vector Biology and Genetics

Shirley Luckhart, Chair
Professor, Dept of Medical Microbiology and Immunology, UC Davis

  • From cross-cutting biology to translation: a necessity for control of mosquito vectors and malaria parasite transmission, Shirley Luckhart
  • Bridging the gap between insecticide resistance surveillance and operational resistance, Anton Cornel
  • Mosquito adaptations to control efforts, Greg Lanzaro
  • Malaria and mosquito control – a California nexus, Steve Mulligan
  • Protein kinase C-dependent signaling controls the epithelial barrier to malaria parasite infection in anopheline mosquitoes, Nazzy Pakpour
  •  Geneticallly modified mosquitoes for malaria control, Yoosook Lee

10:55 am – 11:05 am: Q&A

11:05 am – 11:20 am: Coffee Break

11:20 pm – 12:05 pm Session 2: Technical Innovation

Don Ganem, Chair
Vice President and Global Head of Infectious Disease, Novartis Institutes for BioMedical Research

  • Progress in therapies for malaria, Don Ganem
  • Video: SMS for Life, Novartis
  • High throughput insect ecology, Manu Prakash
  • Anti-malarial and commercial collaborative drug discovery case studies, Barry Bunin
  • Act II, Scene VII , Global Business Enterprises, Charles Bedford
  • The mechanism of action of the benzoxaborole AN6426 against P.falciparum, Ebere Sonoiki
  • Forecasting the landscape: making the case for targeted case management in diagnosis and treatment of malaria,  Aaron Woolsey
  • Antimalarial research at Anacor, Jake Plattner

12:05 pm – 12:15 pm: Q&A

12:15 pm – 1:30 pm: Lunch and Poster Session

1:30 pm – 2:25 pm: Session 3: Implementation of Campaigns, Programs and Policy

Karen Pak Oppenheimer, Chair
Vice President, World Health Partners

  • The social franchising model, Karen Pak Oppenheimer
  • Social franchising & technology to extend the frontier of health service delivery sustainably and at scale, Jacqueline Kingfield
  • Intersectoral partnerships for malaria control in Sabah, Malaysia, Kelly Sanders
  • The VHEMBE study: A birth cohort study investigating potential health effects of indoor residual spraying, Jonathan Chevrier
  • Wide-casting Nothing But Nets, Tamsin Smith
  • Single dose Primaquine: using a historic drug for a new purpose, Roly Gosling
  • Testing market-based and regulatory strategies to improve targeting of artemisinin combination therapies in the Zanzibar private sector, Alexandra Morris POSSIBLE CANCELLATION
  • Avian malaria in a changing world, Ravinder Sehgal
  • WIPO Re:Search, Roopa Ramamoorthi

2:25 pm – 2:35 pm: Q&A

2:35 pm – 2:45 pm: Semi-Synthetic Artemisinin

  • Microbial production of artemisinin,  Melissa Nhan
  • The Artemisinin Project, Chris Paddon, Amyris, Inc.

2:45 pm – 3:15 pm: Closing Remarks and Celebration of Launch

Neil Reninger and Kinkead Reiling, founders Amyris, Inc.

Poster Session

  • WMD-1: Perception of malaria risk in a setting of reduced malaria transmission: a qualitative study in Zanzibar
    Julie Bauch11UCSF
  • WMD-2a: The collaborative drug discovery paradigm: nimble solutions for fast moving science
    Barry Bunin11Collaborative Drug Discovery (CDD), Inc.
  • WMD-2b: Private-private and private-public antimalarial CDD case studies
    Barry Bunin11Collaborative Drug Discovery (CDD), Inc.
  • WMD-3: Comparative population genetics of A. gambiae and A. arabiensis and implication for spread of insecticide resistance in mainland and island Tanzania
    Deodatus Maliti1, Hilary Ranson2, David Weetman2, Gerry Killeen31Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, One Shields Avenue, Davis, CA 95616 2Liverpool School of Tropical Medicine 3Ifakara Health Institute
  • WMD-4: Studying structure-activity relationships of the Plasmodium falciparum chloroquine resistance transporter as a model of undergraduate education in Malaria
    Roland A. Cooper1, Nicole Flordeliza1, Melissa Forbush1, Nyachare Gatkouth1, Andres Gutierrez1, Jessica Hernandez1, Samuel Lemus1, Ian Nickel1, Jillian Nunes1, Stephanie Rasmussen1, Bianca Sanchez Mora1 and Alexis Valdovinos1 1Department of Natural Sciences and Mathematics, Dominican University of California, San Rafael, CA 94901
  • WMD-5: Overexpression of phosphatase and tensin homolog improves fitness and decreases Plasmodium falciparum development in Anopheles stephensi
    Eric S. Hauck11Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, One Shields Avenue, Davis, CA 95616
  • WMD-6: An improved strain for production of semi-synthetic artemisinic acid
    Andrew Horwitz1, Max Schubert1, Andrew Morgenthaler1, Matt Youngblood2, Jack Newman1, Chris Paddon1,1Amyris, Inc. 2CSU Fort Collins, CO
  • WMD-7: The role of abscisic acid in the mosquito response to malaria parasite infection
    Elizabeth Glennon11Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, One Shields Avenue, Davis, CA 95616
  • WMD-7: The role of abscisic acid in the mosquito response to malaria parasite infection
    Elizabeth Glennon11Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, One Shields Avenue, Davis, CA 95616
  • WMD-8 Malaria parasite-induced IL-10 contributes to non-typhoid Salmonella bacteremia
    Kristen Lokken1, Jason Mooney1, and Renée Tsolis11Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, One Shields Avenue, Davis, CA 95616
  • WMD-9 Inducible insulin-like peptide synthesis in Anopheles stephensi: a mechanism for Plasmodium-mediated immunosuppression
    Jose Pietri1 and Shirley Luckhart11Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, One Shields Avenue, Davis, CA 95616
  • WMD-10 Going beyond malaria in Tanzania
    Pam Sullivan1, Jehane Jones1, Sarah Jones Wenzel11Tanzania Health & Education Mission
  • WMD-11 Discovery of benzoxaborole as antimalarial agents
    Yong Kang Zhang1, Jake Plattner1, Eric Easom11Anacor Pharmaceuticals
  • WMD-12 T32
    Gregory Lanzaro11UC Davis School of Veterinary Medicine
  • WMD-13 Vector genetics lab
    Gregory Lanzaro11UC Davis School of Veterinary Medicine
  • WMD-14 p38 MAPK signaling in Anopheles stephensi: a mechanism for tolerance or resistance during parasite infection?
    Bo Wang11Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, One Shields Avenue, Davis, CA 95616
  • WMD-15a For Information
    UC Davis School of Medicine
  • WMD-15b For Information
    UC Davis School of Medicine
  • WMD-16a For Information
    UC Davis School of Veterinary Medicine
  • WMD-16b For Information
    UC Davis School of Veterinary Medicine